In vitro studies [150] revealed that SSc fibroblasts exhibit greater resistance to Fas-mediated apoptosis and lower ASMase and transforming growth factor beta (TGFβ) expression, with the latter being an important fibrogenic cytokine in SSc. This evidence concerns the gene FAS and systemic sclerosis.